Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: REGENTS OF THE UNIVERSITY OF MICHIGAN
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2017-04-24 to 2021-10-31
Current total value of award: $11809696.72
Description: TARGETED CLINICAL TRIALS TO REDUCE THE RISK OF ANTIMICROBIAL RESISTANCE: RANDOMIZED CONTROLLED TRIAL FOR TREATMENT OF MULTI-DRUG RESISTANT ACINETOBACTER BAUMANII